Published in Clin Exp Nephrol on October 31, 2013
The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology. Adv Lipid Res (1973) 2.12
Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest (1990) 2.08
Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by elctron microscopy. J Clin Invest (1971) 1.63
Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency. Lancet (1991) 1.56
Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis (1990) 1.22
Genetics of LCAT (lecithin: cholesterol acyltransferase) deficiency. Ann Hum Genet (1975) 1.03
Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency. J Am Soc Nephrol (2013) 0.99
Familial LCAT deficiency: from renal replacement to enzyme replacement. Neth J Med (2013) 0.92
Renal failure in familial lecithin: cholesterol acyltransferase deficiency. Q J Med (1982) 0.86
Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome. Am J Physiol Renal Physiol (2001) 0.85
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs). Clin Nephrol (2008) 0.82
Long-term follow-up of a patient with lecithin cholesterol acyltransferase deficiency syndrome after kidney transplantation. Transplantation (1993) 0.81
Familial lecithin:cholesterol acyltransferase deficiency - a new metabolic disease with renal involvement. Adv Nephrol Necker Hosp (1981) 0.81
Lecithin cholesterol acyltransferase deficiency: ultrastructural examination of sequential renal biopsies. Mod Pathol (1991) 0.81
Studies on the protein moiety of serum high density lipoprotein from patients with familial lecithin: cholesterol acyltransferase deficiency. Clin Genet (1972) 0.81
Molecular defect in familial lecithin:cholesterol acyltransferase (LCAT) deficiency: a single nucleotide insertion in LCAT gene causes a complete deficient type of the disease. Biochem Biophys Res Commun (1991) 0.81
Mutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996--. J Atheroscler Thromb (2004) 0.81
Point mutation (C to T) of the LCAT gene resulting in A140C substitution. J Atheroscler Thromb (2010) 0.78
A new case of familial lecithin: cholesterol acyltransferase (LCAT) deficiency--paradoxical findings regarding LCAT mass and activity in 23 members of a family. Jpn J Med (1990) 0.76
Corneal and macular manifestations in a case of deficient lecithin: cholesterol acyltransferase. Jpn J Ophthalmol (2004) 0.75
Two different allelic mutations in a Finnish family with lecithin:cholesterol acyltransferase deficiency. Arterioscler Thromb Vasc Biol (1995) 0.75
Lecithin:cholesterol acyl transferase deficiency presenting as visual impairment, with hypocholesterolaemia and normal renal function. Scand J Clin Lab Invest Suppl (1978) 0.75
A single G to A nucleotide transition in exon IV of the lecithin: cholesterol acyltransferase (LCAT) gene results in an Arg140 to His substitution and causes LCAT-deficiency. Hum Genet (1995) 0.75
Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstruction. Radiology (2010) 2.08
Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol (2003) 1.79
PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Invest (2008) 1.68
Different risk factors for the maximum and the mean carotid intima-media thickness in hemodialysis patients. Intern Med (2003) 1.39
Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem Biophys Res Commun (2006) 1.33
Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int (2003) 1.30
Phthalic acid diamides activate ryanodine-sensitive Ca2+ release channels in insects. Cell Calcium (2005) 1.14
The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol (2004) 1.12
Matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight (MALDI-QIT-TOF)-based imaging mass spectrometry reveals a layered distribution of phospholipid molecular species in the mouse retina. Rapid Commun Mass Spectrom (2008) 1.10
Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction. Nephrology (Carlton) (2007) 1.08
Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling. Kidney Int (2013) 0.99
Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis. Nephrol Dial Transplant (2008) 0.97
Molecular characterization of flubendiamide sensitivity in the lepidopterous ryanodine receptor Ca(2+) release channel. Biochemistry (2009) 0.94
Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1/2 and p38 MAPK. Kidney Int (2005) 0.89
Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model. Nephron Exp Nephrol (2009) 0.88
Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury. Transplantation (2007) 0.87
Salamander retina phospholipids and their localization by MALDI imaging mass spectrometry at cellular size resolution. J Lipid Res (2010) 0.86
Quantitative gene-expression analysis of the ligand-receptor system for classical neurotransmitters and neuropeptides in hippocampal CA1, CA3, and dentate gyrus. Hippocampus (2010) 0.84
Tgf-beta1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells. Perit Dial Int (2005) 0.84
Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2. Ther Apher Dial (2007) 0.83
Gene expression profiling of neuropeptides in mouse cerebellum, hippocampus, and retina. Nutrition (2008) 0.82
A high recovery microsampling device based on a microdialysis probe for peptide sampling. Anal Biochem (2010) 0.81
Extracellular signal-regulated kinase-dependent interstitial macrophage proliferation in the obstructed mouse kidney. Nephrology (Carlton) (2008) 0.78
Effect of lactate and bicarbonate on human peritoneal mesothelial cells, fibroblasts and vascular endothelial cells, and the role of basic fibroblast growth factor. Nephrol Dial Transplant (2004) 0.78
An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease. J Nephrol (2008) 0.78
Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis. Clin Exp Nephrol (2013) 0.78
Point mutation (C to T) of the LCAT gene resulting in A140C substitution. J Atheroscler Thromb (2010) 0.78
Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patients. Ther Apher Dial (2008) 0.78
Ligand-independent androgen receptor antagonism caused by the newly developed pesticide pyrifluquinazon (PFQ). Reprod Toxicol (2012) 0.77
15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells. Ther Apher Dial (2010) 0.77
Viability of, and basic fibroblast growth factor secretion by, human peritoneal mesothelial cells cultured with various components of peritoneal dialysis fluid. Adv Perit Dial (2003) 0.77
C-C chemokine receptor 2 expression by circulating monocytes influences atherosclerosis in patients on chronic hemodialysis. Ther Apher Dial (2009) 0.77
Increased serum osteoprotegerin level in older and diabetic hemodialysis patients. Ther Apher Dial (2004) 0.77
Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels. Bone (2004) 0.76
Construction of a metagenomic library for the marine sponge Halichondria okadai. Biosci Biotechnol Biochem (2012) 0.75
Efficacy of add-on therapy of aliskiren to an angiotensin II receptor blocker on renal outcomes in advanced-stage chronic kidney disease: a prospective, randomized, open-label study. Clin Exp Nephrol (2014) 0.75
The serum lipids levels may be underestimated in patients on hemodialysis. Intern Med (2015) 0.75
Klotho as a Therapeutic Target during the Development of Renal Fibrosis. Contrib Nephrol (2016) 0.75
Successful treatment with plasma exchange for ANCA-negative pauci-immune crescentic glomerulonephritis with D-negative hemolytic uremic syndrome. Clin Nephrol (2014) 0.75
Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype. Virchows Arch (2015) 0.75
[N-terminal pro brain natriuretic peptide predicts hospitalization of hemodialysis patients for cardiovascular disease]. Nihon Jinzo Gakkai Shi (2011) 0.75
Serum cross-linked N-terminal telopeptide of type I collagen for evaluation of renal osteodystrophy in hemodialysis patients. Nephron Clin Pract (2005) 0.75
[Nephrotic syndrome]. Nihon Jinzo Gakkai Shi (2012) 0.75
Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients. Clin Exp Nephrol (2012) 0.75
Performance of polysulfone membrane dialyzers and dialysate flow pattern. Clin Exp Nephrol (2006) 0.75